Suppr超能文献

调节性 T 细胞对慢性丙型肝炎发病机制的不同贡献。

Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C.

机构信息

Department of Medicine; Rhode Island Hospital and the Warren Alpert Medical School of Brown University; Providence, RI USA.

出版信息

Hum Vaccin Immunother. 2013 Jul;9(7):1569-76. doi: 10.4161/hv.24726. Epub 2013 May 31.

Abstract

Hepatitis C virus, a small single-stranded RNA virus, is a major cause of chronic liver disease. Resolution of primary hepatitis C virus infections depends upon the vigorous responses of CD4(+) and CD8(+) T cells to multiple viral epitopes. Although such broad CD4(+) and CD8(+) T-cell responses are readily detected early during the course of infection regardless of clinical outcome, they are not maintained in individuals who develop chronic disease. Purportedly, a variety of factors contribute to the diminished T-cell responses observed in chronic, virus-infected patients including the induction of and biological suppression by CD4(+)FoxP3(+) regulatory T cells. Indeed, a wealth of evidence suggests that regulatory T cells play diverse roles in the pathogenesis of chronic hepatitis C, impairing the effector T-cell response and viral clearance early during the course of infection and suppressing liver injury as the disease progresses. The factors that affect the generation and biological response of regulatory T cells in chronic, hepatitis C virus-infected patients is discussed.

摘要

丙型肝炎病毒是一种小型单链 RNA 病毒,是慢性肝病的主要病因。丙型肝炎病毒初次感染的清除依赖于 CD4(+)和 CD8(+)T 细胞对多种病毒表位的强烈应答。尽管在感染过程中无论临床结局如何,早期就可以轻易检测到这种广泛的 CD4(+)和 CD8(+)T 细胞应答,但在发生慢性疾病的个体中却无法维持。据称,多种因素导致慢性、病毒感染患者 T 细胞应答减弱,包括 CD4(+)FoxP3(+)调节性 T 细胞的诱导和生物学抑制。事实上,大量证据表明,调节性 T 细胞在慢性丙型肝炎的发病机制中发挥多种作用,在感染过程早期削弱效应 T 细胞应答和病毒清除,并在疾病进展过程中抑制肝损伤。本文讨论了影响慢性丙型肝炎病毒感染患者调节性 T 细胞生成和生物学反应的因素。

相似文献

1
Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C.
Hum Vaccin Immunother. 2013 Jul;9(7):1569-76. doi: 10.4161/hv.24726. Epub 2013 May 31.
2
Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.
Virulence. 2012 Nov 15;3(7):610-20. doi: 10.4161/viru.21823. Epub 2012 Oct 17.
3
FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
Gastroenterology. 2009 Oct;137(4):1280-8.e1-6. doi: 10.1053/j.gastro.2009.06.059. Epub 2009 Jul 29.
6
Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
Arch Virol. 2018 Apr;163(4):855-865. doi: 10.1007/s00705-017-3675-8. Epub 2017 Dec 16.
9
Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
J Virol. 2015 May;89(10):5478-90. doi: 10.1128/JVI.03717-14. Epub 2015 Mar 4.

引用本文的文献

2
Tocilizumab Induces IL-10-Mediated Immune Tolerance in Invasive Candidiasis.
J Fungi (Basel). 2021 Aug 13;7(8):656. doi: 10.3390/jof7080656.
3
Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination.
Front Immunol. 2015 May 11;6:217. doi: 10.3389/fimmu.2015.00217. eCollection 2015.
4
Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.
Front Microbiol. 2014 Oct 6;5:502. doi: 10.3389/fmicb.2014.00502. eCollection 2014.
5
Report from the field: Overview of the Sixth Annual Vaccine Renaissance Conference.
Hum Vaccin Immunother. 2013 Jul;9(7):1555-7. doi: 10.4161/hv.24833. Epub 2013 May 31.
6
The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix.
Hum Vaccin Immunother. 2013 Jul;9(7):1577-86. doi: 10.4161/hv.24615. Epub 2013 Apr 12.

本文引用的文献

1
Animal models for hepatitis C.
Curr Top Microbiol Immunol. 2013;369:49-86. doi: 10.1007/978-3-642-27340-7_3.
2
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.
J Exp Med. 2012 Sep 24;209(10):1713-22, S1-19. doi: 10.1084/jem.20120822. Epub 2012 Sep 10.
3
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells.
J Exp Med. 2012 Sep 24;209(10):1723-42, S1. doi: 10.1084/jem.20120914. Epub 2012 Sep 10.
4
Anti-hepatitis C virus drugs in development.
Gastroenterology. 2012 May;142(6):1340-1350.e1. doi: 10.1053/j.gastro.2012.02.015.
5
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.
Ann Intern Med. 2012 Feb 21;156(4):279-90. doi: 10.7326/0003-4819-156-4-201202210-00005.
6
HCV: Written in our DNA.
Self Nonself. 2011 Apr;2(2):108-113. doi: 10.4161/self.2.2.15795. Epub 2011 Apr 1.
8
The battle against immunopathology: infectious tolerance mediated by regulatory T cells.
Cell Mol Life Sci. 2012 Jun;69(12):1997-2008. doi: 10.1007/s00018-011-0907-z. Epub 2011 Dec 29.
9
Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions.
Semin Immunol. 2011 Dec;23(6):424-30. doi: 10.1016/j.smim.2011.10.002. Epub 2011 Nov 3.
10
Peripheral education of the immune system by colonic commensal microbiota.
Nature. 2011 Sep 21;478(7368):250-4. doi: 10.1038/nature10434.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验